RE:RE:SNN Revenuesunrize wrote: It's a good start. However, I am cautiously optimistic about the sales piece. What really matters is the profit margin on those secured sales. Revenue from the supply agreement with Canopy? That is miles and miles away. According to management, they are working on the agreement.
EquityInvest wrote: The closing of LYTR acquisition, securing US $2.4M product sales, spin-off of US company in progress - all contributed to last week's sp run. I'm hoping that SNN will continue to realize increased sales of high-margin products to eliminate the need for another pp and finish the facility construction on time.
Another unaccounted for revenue is from the supply agreement with Canopy. I have not seen any update on this. Does anyone on Board know the status of this agreement (is it still active)?
Thank you in advance.
EI
For the Canadian site they are now building with the pod approach to maximize the profits they can make with NHS by selling their own supply to their existing clients. Which is a smart idea, because until the spinout happens they do not have the ability to obtain financing with the US assets attached. They plan to build out in phases to complete the original design, through vendor financing. This is where imo canopy could still become a partner at some point. Hence why management is still in negotiations with them by the sounds of it. As sunrise said though this is probably not right in the distant future.